NCT06568718View on ClinicalTrials.gov

Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Lower Urinary Tract SymptomsProstatic Hyperplasia
Interventions
DRUG

bovhyaluronidase azoximer

Longidaze 3000 IU intramuscularly once every 5 days with a course of 5 injections; Longidaze 3000 IU rectal suppositories once every 3 days with a course of 10 applications; Longidaze 3000 IU rectal suppositories once every 7 days with a course of 10 applications.

DRUG

tamsulosin

Tamsulosin 0.4mg per os every day

Trial Locations (3)

150001

"LLC Clinic of Modern Medicine of Dr. Bogorodskaya", Yaroslavl

197022

First Saint Petersburg State Medical University named after academician I.P. Pavlov, Saint Petersburg

350000

"LLC Krasnodar Medical and Biological Center", Krasnodar

All Listed Sponsors
lead

NPO Petrovax

INDUSTRY